Published July 2014 | Version v1
Journal article

High-dose intravenous metoprolol usage for reducing heart rate at CT coronary angiography: Efficacy and safety

  • 1. Radiology Department, Plymouth Hospitals NHS Trust, Plymouth, Devon PL6 8DH (United Kingdom)
  • 2. Cardiology Department, Musgrove Park Hospital, Taunton, Somerset TA1 5DA (United Kingdom)
  • 3. Cardiology Department, Plymouth Hospitals NHS Trust, Plymouth, Devon PL6 8DH (United Kingdom)
  • 4. Radiology Department, Royal Free Hospital, London NW3 2QG (United Kingdom)

Description

Aim: To evaluate the usage, safety, and efficacy of high-dose intravenous metoprolol for heart rate reduction in computer tomographic (CT) coronary angiography. Materials and methods: As this was retrospective analysis of anonymous data, medical ethics committee approval was waived by the regional health research authority. Patients, who had known iodinated contrast medium allergy, contraindications to β-blockers, atrial fibrillation, and indications other than suspected coronary artery disease, were excluded from analysis. The ultimate study population of 662 were analysed with details of intravenous metoprolol doses, complications, heart rate before administration of intravenous metoprolol (resting heart rate, RHR), heart rate at acquisition of scan (acquisition heart rate, AHR), and usage of low radiation dose protocols. Results: Of the ultimate study population of 662 patients, 183 had no intravenous metoprolol with mean acquisition heart rate (AHR) of 58 beats per minute (bpm), 257 had 1–15 mg intravenous metoprolol with mean AHR of 57 bpm, 114 had 16–29 mg intravenous metoprolol with mean AHR of 62 bpm and 108 had ≥30 mg intravenous metoprolol with mean AHR of 66 bpm. In the group receiving intravenous metoprolol, average usage was 19 mg (maximum 67 mg) with average reduction in HR of 15 bpm. There were no clinical incidents in relation to the use of high-dose intravenous metoprolol. Conclusion: Higher doses of intravenous metoprolol are beneficial in achieving target heart rates to facilitate usage of low radiation dose protocols. With appropriate exclusion criteria, higher doses of intravenous metoprolol, well in excess of 15 mg, can be safely administered when carefully titrated. - Highlights: • We evaluate intravenous metoprolol usage in a mature cardiac CT imaging service. • Intravenous metoprolol is beneficial to achieve lower heart rates for CTCA. • IV metoprolol doses in excess of 15 mg is efficacious and safe with careful titration

Availability note (English)

Available from http://dx.doi.org/10.1016/j.crad.2014.03.003

Additional details

Identifiers

DOI
10.1016/j.crad.2014.03.003;
PII
S0009-9260(14)00103-2;

Publishing Information

Journal Title
Clinical Radiology
Journal Volume
69
Journal Issue
7
Journal Page Range
p. 739-744
ISSN
0009-9260
CODEN
CLRAAG

INIS

Country of Publication
United Kingdom
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
46120161
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Descriptors DEI
ALLERGY; BIOMEDICAL RADIOGRAPHY; COMPUTERIZED TOMOGRAPHY; CONTRAST MEDIA; CORONARIES; ETHICAL ASPECTS; HEART; PATIENTS; RADIATION DOSES
Descriptors DEC
ARTERIES; BLOOD VESSELS; BODY; CARDIOVASCULAR SYSTEM; DIAGNOSTIC TECHNIQUES; DOSES; MEDICINE; NUCLEAR MEDICINE; ORGANS; PATHOLOGICAL CHANGES; RADIOLOGY; TOMOGRAPHY

Optional Information

Copyright
Copyright (c) 2014 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.